Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

ENTREMED INC
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA532012Executive Chairman
Cynthia Wong Hu482006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA512011Chief Accounting Officer & Vice President-Finance
Alexander A. Zukiwski, MD602017Chief Medical Officer
Zuie Chin Huang, MBA522013Independent Director
Yue Wu PhD, MBA542013Independent Director
Franklin Cary Salisbury, Jr.622014Independent Director
Rajesh C. Shrotriya, MD742014Independent Director
Quan Zhou, PhD602016Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 65,146,109 32,113,849 49.3% 79,545 0.1% 49.3%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 11,547,675 16.5%
Hexie Aiqi Investment Management Beijing Co., Ltd. 8,498,765 12.2%
Hung Ka Kung 6,296,292 9.01%
IDG Capital Partners Co., Ltd. 5,452,385 7.80%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 7.06%
Emerging Technology Partners LLC 2,312,677 3.31%
The Vanguard Group, Inc. 926,844 1.33%
Wei-Wu He PhD, MBA 847,527 1.21%
Wellington Shields Capital Management LLC 725,348 1.04%
Wellington Shields & Co. LLC (Investment Management) 445,118 0.64%
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC250
CELLTRION, INC.--.--%36 184
IQVIA HOLDINGS INC6.93%21 157
LONZA GROUP-7.82%18 346
INCYTE CORPORATION-6.91%18 156
NEKTAR THERAPEUTICS40.66%13 138
ALNYLAM PHARMACEUTICALS, INC.-5.56%12 005
ALKERMES PLC8.33%10 343
QIAGEN6.79%7 897
SEATTLE GENETICS, INC.1.05%7 841
SAGE THERAPEUTICS INC-0.67%6 666
IONIS PHARMACEUTICALS INC-3.90%6 246
ICON PLC1.52%6 215
GALAPAGOS17.12%5 866
EXACT SCIENCES CORPORATION-6.59%5 850
UNITED THERAPEUTICS CORPORATION-7.46%5 830
PRA HEALTH SCIENCES INC-2.09%5 634
BIO-TECHNE CORP8.88%5 290
CHARLES RIVER LABORATORIES INTL. INC0.79%5 128
FIBROGEN INC18.99%4 644
ABLYNX111.00%4 069
Connections : EntreMed Inc
Cs Family Trust
Emerging Technology Partners LLC
American-Sino OB/GYN Hospital
MithraGen, Inc.
IDG Capital Partners Co., Ltd.
Wuhan Kindstar Co. Ltd.
The UNLV Foundation
CVie Therapeutics Co. Ltd.
Beijing Genetron Biotechnology Co. Ltd.
Zenesis Ltd.
Circle Internet Financial Ltd.
OMNI Pharmaceuticals (USA), Inc.
Human Longevity, Inc.
Smooth Prosper Ltd.
Shrotriya Family Foundation
GenScript Corp.
Spectrum Pharmaceuticals Cayman LP
KPCB China Fund II LP
OriGene Technologies, Inc.
IDG Technology Venture Investment III LLC
WUPIMA, Inc.
Superdata Software Holdings Ltd.
Creditease Holdings Cayman Ltd.
Intradigm Corp.
MZ Investment Holdings Ltd.
Allos Therapeutics, Inc.
IDG Technology Venture Investments LP
National Foundation for Cancer Research
IDG Technology Venture Investment IV LLC
© 2018 People , Fundamentals and Ownership